These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32326425)
21. Shining light on the head: Photobiomodulation for brain disorders. Hamblin MR BBA Clin; 2016 Dec; 6():113-124. PubMed ID: 27752476 [TBL] [Abstract][Full Text] [Related]
22. Exploring the Effect of Combined Transcranial and Intra-Oral Photobiomodulation Therapy Over a Four-Week Period on Physical and Cognitive Outcome Measures for People with Parkinson's Disease: A Randomized Double-Blind Placebo-Controlled Pilot Study. Bullock-Saxton J; Lehn A; Laakso EL J Alzheimers Dis; 2021; 83(4):1499-1512. PubMed ID: 34092640 [TBL] [Abstract][Full Text] [Related]
23. Effect of Photobiomodulation in Rescuing Lipopolysaccharide-Induced Dopaminergic Cell Loss in the Male Sprague-Dawley Rat. O'Brien JA; Austin PJ Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430990 [TBL] [Abstract][Full Text] [Related]
24. "Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome? Liebert A; Bicknell B; Johnstone DM; Gordon LC; Kiat H; Hamblin MR Photobiomodul Photomed Laser Surg; 2019 Nov; 37(11):681-693. PubMed ID: 31596658 [No Abstract] [Full Text] [Related]
25. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ Support Care Cancer; 2016 Jun; 24(6):2793-805. PubMed ID: 26984249 [TBL] [Abstract][Full Text] [Related]
26. Brain photobiomodulation therapy on neurological and psychological diseases. Chamkouri H; Liu Q; Zhang Y; Chen C; Chen L J Biophotonics; 2024 Jan; 17(1):e202300145. PubMed ID: 37403428 [TBL] [Abstract][Full Text] [Related]
27. Systematic Review of Delivery Parameters Used in Dental Photobiomodulation Therapy. Parker S; Cronshaw M; Anagnostaki E; Bordin-Aykroyd SR; Lynch E Photobiomodul Photomed Laser Surg; 2019 Dec; 37(12):784-797. PubMed ID: 31573388 [No Abstract] [Full Text] [Related]
28. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Cassano P; Petrie SR; Hamblin MR; Henderson TA; Iosifescu DV Neurophotonics; 2016 Jul; 3(3):031404. PubMed ID: 26989758 [TBL] [Abstract][Full Text] [Related]
29. Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies. Salehpour F; Khademi M; Hamblin MR J Alzheimers Dis; 2021; 83(4):1431-1452. PubMed ID: 33935090 [TBL] [Abstract][Full Text] [Related]
30. Transcranial near-infrared photobiomodulation could modulate brain electrophysiological features and attentional performance in healthy young adults. Jahan A; Nazari MA; Mahmoudi J; Salehpour F; Salimi MM Lasers Med Sci; 2019 Aug; 34(6):1193-1200. PubMed ID: 31011865 [TBL] [Abstract][Full Text] [Related]
31. Photobiomodulation and the brain: a new paradigm. Hennessy M; Hamblin MR J Opt; 2017 Jan; 19(1):013003. PubMed ID: 28580093 [TBL] [Abstract][Full Text] [Related]
32. Therapies for Parkinson's diseases: alternatives to current pharmacological interventions. Li S; Dong J; Cheng C; Le W J Neural Transm (Vienna); 2016 Nov; 123(11):1279-1299. PubMed ID: 27515029 [TBL] [Abstract][Full Text] [Related]
33. Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation. Cassano P; Caldieraro MA; Norton R; Mischoulon D; Trinh NH; Nyer M; Dording C; Hamblin MR; Campbell B; Iosifescu DV Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):651-656. PubMed ID: 31647774 [No Abstract] [Full Text] [Related]
34. Photobiomodulation for the aging brain. Cardoso FDS; Gonzalez-Lima F; Gomes da Silva S Ageing Res Rev; 2021 Sep; 70():101415. PubMed ID: 34325071 [TBL] [Abstract][Full Text] [Related]
35. Role of chemokines in Parkinson's disease. Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787 [TBL] [Abstract][Full Text] [Related]
36. Effects of Near-Infrared Light on Cerebral Bioenergetics Measured with Phosphorus Magnetic Resonance Spectroscopy. Mintzopoulos D; Gillis TE; Tedford CE; Kaufman MJ Photomed Laser Surg; 2017 Aug; 35(8):395-400. PubMed ID: 28186868 [TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease: Autoimmunity and neuroinflammation. De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913 [TBL] [Abstract][Full Text] [Related]
38. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Cassano P; Dording C; Thomas G; Foster S; Yeung A; Uchida M; Hamblin MR; Bui E; Fava M; Mischoulon D; Iosifescu DV Lasers Surg Med; 2019 Feb; 51(2):127-135. PubMed ID: 30221776 [TBL] [Abstract][Full Text] [Related]
39. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease. Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482 [TBL] [Abstract][Full Text] [Related]
40. Photobiomodulation and Cancer: What Is the Truth? Hamblin MR; Nelson ST; Strahan JR Photomed Laser Surg; 2018 May; 36(5):241-245. PubMed ID: 29466089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]